Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0430
+0.0010 (2.38%)
Aug 14, 2025, 10:02 AM EDT
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $5.32 million as of August 14, 2025. Its market cap has decreased by -88.00% in one year.
Market Cap
5.32M
Enterprise Value
-10.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 5.32M, a decrease of -99.74%. That is a compound annual growth rate of -79.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 5.45M | 760.00% |
| Dec 31, 2024 | 633.74K | -99.41% |
| Dec 29, 2023 | 107.73M | -38.95% |
| Dec 30, 2022 | 176.48M | -74.91% |
| Dec 31, 2021 | 703.46M | -66.12% |
| Nov 11, 2021 | 2.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 560.80M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 367.14M |
| CytoDyn | 300.75M |